Insider holders · CIK 0001533040
Phio Pharmaceuticals Corp. · PHIO
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Alexey EliseevChief Business Officer | 950,312 | — | 950,312 | Sep 7, 2017 · 8:17 pm EDT | Form 4 |
| Geert CauwenberghChief Executive Officer | 481,592 | 450 | 482,042 | Mar 1, 2019 · 9:24 am EST | Form 4 |
| Gerrit DispersynPresident & CEO | 479,053 | — | 479,053 | Mar 5, 2019 · 9:01 pm EST | Form 4 |
| Robert J BittermanChairman, Pres. & CEO | 364,871 | — | 364,871 | Sep 23, 2026 · 4:01 pm EDT | Form 4 |
| Lisa Cabott CarsonChief Financial Officer | 81,112 | — | 81,112 | Sep 15, 2026 · 4:00 pm EDT | Form 4 |
| Patricia A BradfordDirector | 64,151 | — | 64,151 | Sep 25, 2026 · 4:01 pm EDT | Form 4 |
| Caitlin KontulisSecretary & Sr. Dir. Finance | 40,214 | — | 40,214 | Feb 15, 2019 · 9:02 pm EST | Form 4 |
| H. Paul DormanDirector | 20,375 | — | 20,375 | Feb 15, 2019 · 9:08 pm EST | Form 4 |
| Curtis LockshinDirector | 20,130 | — | 20,130 | Feb 15, 2019 · 9:09 pm EST | Form 4 |
| Jonathan E FreemanDirector | 20,000 | — | 20,000 | Feb 15, 2019 · 9:11 pm EST | Form 4 |
| Keith L BrownlieDirector | 20,000 | — | 20,000 | Feb 15, 2019 · 9:06 pm EST | Form 4 |
| Pamela PavcoChief Development Officer | 17,173 | — | 17,173 | Dec 20, 2016 · 9:25 pm EST | Form 4 |
| Ronald Todd PlottDirector | 15,000 | — | 15,000 | Aug 20, 2026 · 8:30 am EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.